Testing Two Different Drugs (Sacituzumab-govitecan and Trastuzumab-deruxtecan) Combinations Prescribed in an Alterning Pattern to Patients With Metastatic or Locally Advanced Triple-negative Breast Cancer

Clinical trial NCT07151586 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07151586
Sponsor: UNICANCER
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Triple Negative Breast Neoplasms Neoplasm Metastasis HER 2 Low-expressing Breast Cancer

Start date: 2026-09-01
Primary completion: 2029-10-01
Enrollment: 260

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.